UPB Upstream Bio Inc Future Price to Earnings
Upstream Bio Inc revenues are based on the upcoming market launch of UPB-101 antibodies for asthma. The company's forward P/E ratio reflects the business valuation trend, where the parameter is 0.00. Professional management strictly adheres to clinical trial discipline, and the development of the entire ecosystem currently depends entirely on FDA regulatory verdicts.
Upstream Pharma (UPB) - metric breakdowns and financial figures
- stock quotes and analyst forecast:
- market capitalization data:
- balance sheet equity data:
- issuer credit burden and liquidity indicators:
- company profitability and valuation multiples indicators:
UPB - Net Financial Result|Future Profit Upstream Bio Inc|UPB - Market Price to Net Income Ratio|Future Price to Earnings Upstream Bio Corp|UPB - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Upstream Bio, Inc.|UPB - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) Upstream Bio|UPB - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months upstreambio.com|UPB - Net earnings per share growth this year|Expected earnings per share growth for next year Upstream Bio Inc
Analysis of all company metrics:Upstream Bio UPB
Forward P/E assesses the fairness of market value through the lens of projected earnings. Analyzing the forward price-to-earnings ratio of Upstream Bio Inc (UPB) on the GURU.Markets platform allows investors to filter out speculative noise from fundamental trends. The current value of 0.00 is driven by the ratio of market capitalization to expected net income. The metric's dynamics reflect market expectations for the commercialization of verequitumag. Inelastic demand for severe asthma therapy provides Upstream Bio Inc (UPB) with significant pricing power.
Analysis of competing companies
Forward P/E Multiple ARGX|Market Cap to Projected Earnings BioNTech Inc.|Future Price to Earnings abivax.com ABVX|ADMA - Projected Price to Earnings|PTGX - Future Price to Earnings|immunovant.com (IMVT) - Projected Price to Earnings|KNSA (Kiniksa) - Projected Price to Earnings|Grifols SA (GRFS) - Forward P/E Multiple|Future Price to Earnings Adaptive Biotechnologies Corp|Price to Future Earnings Ratio CLDX (Celldex Corp)|Forward P/E Multiple AUPH|BCRX - Projected Price to Earnings Ratio|Vera Therapeutics - Projected Price to Earnings|Forward P/E Multiple Dianthus Therapeutics Inc DNTH|PHVS - Future Price to Earnings|Price to Expected Earnings Ratio ABCL|Tourmaline Bio, Inc. (TRML) - Future Price to Earnings|PGEN - Market Cap to Projected Earnings|Projected Price to Earnings PHAR|NKTR (Nektar Therapeutics Inc) - Market Cap to Future Earnings Ratio|Future Price to Earnings Zenas Biopharma, Inc. (ZBIO)|IMNM (Immunome Bio) - Future Price to Earnings Multiple|Forward P/E Multiple GOSS (Gossamer Bio, Inc.)|kalvista.com (KALV) - Projected Price to Earnings Ratio|Septerna - Forward P/E Multiple|PVLA - Forward P/E Multiple|Savara Corp (SVRA) - Future Price to Earnings|Projected Price to Earnings Rigel Corp|Projected Price to Earnings ANAB|ATXS: Future Price to Earnings Multiple|Forward P/E Multiple ENGN|Future Price to Earnings RAPT (RAPT Therapeutics Inc.)|Forward P/E Multiple JBIO (Aerovate Therapeutics)|Market Cap to Projected Earnings Aclaris Therapeutics, Inc (ACRS)|KYTX - Future Price to Earnings|Projected Price to Earnings Ratio tizianalifesciences.com|CABA (Cabaletta Bio) - Projected Price to Earnings|Ventyx Biosciences Inc. - Future Price to Earnings Multiple|THTX (Theratechnologies Inc) - Forward P/E Multiple|Avalo Therapeutics Inc (AVTX) - Market Cap to Projected Earnings|Future Price to Earnings Eledon Pharmaceuticals (ELDN)|agenusbio.com - Price to Future Earnings Ratio|Forward P/E Multiple CLYM (Climb Bio)|ZURA - Projected Price to Earnings|ATYR: Projected Price to Earnings|ADAG - Forward P/E Multiple|ikenaoncology.com (IMA) - Future Price to Earnings|Price to Expected Earnings Ratio STTK (Shattuck Labs)|EQ (Equillium Inc) - Forward P/E Multiple|Future Price to Earnings CNTB|Future Price to Earnings Immunic, Inc. (IMUX)|ATRA: Price to Expected Earnings Ratio|Forward P/E Multiple IFRX (InflaRx)|Future Price to Earnings Multiple XFOR|Adicet - Forward P/E Multiple|CELU - Forward P/E Multiple|INmune Bio Corp (INMB) - Future Price to Earnings|Barinthus Biotherapeutics Corp - Future Price to Earnings Multiple|Future Price to Earnings Kezar Life Sciences|Projected Price to Earnings sabbiotherapeutics.com (SABS)|Forward P/E Multiple AKTX|Forward P/E Multiple enlivex.com (ENLV)|Q32 Bio - Projected Price to Earnings|Future Price to Earnings Multiple GOVX|Edesa Biotech, Inc. - Forward P/E Multiple|Market Cap to Projected Earnings ibioinc.com IBIO|carismatx.com (CARM) - Future Price to Earnings|Projected Price to Earnings XTL Biopharmaceuticals Ltd|Future Price to Earnings Bolt Biotherapeutics Inc.|Projected Price to Earnings HCW Biologics Inc (HCWB)|Projected Price to Earnings APVO (Aptevo Therapeutics)|Forward P/E Multiple AIM ImmunoTech, Inc. (AIM)|Future Price to Earnings Aditxt, Inc. ADTX|GRI: Price to Future Earnings Ratio|XORTX - Forward P/E Multiple|Projected Price to Earnings Ratio Vyome Therapeutics|REVB (Revelation Biosciences) - Projected Price to Earnings|indaptusrx.com (INDP) - Forward P/E Multiple|Future Price to Earnings Scinai Immunotherapeutics Ltd.|CalciMedica Corp - Price to Expected Earnings Ratio|Future Price to Earnings Affimed (AFMD)|Market Cap to Projected Earnings allakos.com|HOOKIPA Pharma - Projected Price to Earnings|Market Cap to Future Earnings Ratio IGMS (IGM Biosciences Inc.)|ITOS - Future Price to Earnings|Future Price to Earnings Multiple OCEA (Ocean Biomedical Inc)|TCBP: Forward P/E Multiple|Projected Price to Earnings Ratio Third Harmonic Bio Inc (THRD)
